Regulatory T Cell Selective IL-2-Fc Fusion Proteins for the Treatment of Autoimmune Diseases

白细胞介素2受体 FOXP3型 免疫学 效应器 细胞生物学 白细胞介素2 免疫系统 CD8型 调节性T细胞 生物 T细胞 融合蛋白 细胞因子 化学 生物化学 基因 重组DNA
作者
Rajat Varma,Ke Liu,Kendra N. Avery,Rumana Rashid,Suzanne Schubbert,Irene Leung,Christine Bonzon,Liz Bogaert,John R. Desjarlais,Matthew J. Bernett
出处
期刊:Blood [Elsevier BV]
卷期号:132 (Supplement 1): 3709-3709 被引量:4
标识
DOI:10.1182/blood-2018-99-117622
摘要

Abstract Regulatory T cells (Tregs) characterized as CD4 positive cells, expressing CD25 (IL-2Rα) and the forkhead transcription factor FoxP3 maintain immune tolerance in tissues by suppressing the function of both CD4 and CD8 effector T cells. It is well documented that there is a paucity and/or dysfunction of Tregs in most autoimmune diseases and therefore a promising therapeutic approach has been to restore their numbers and function. Treg homeostasis depends on IL-2 derived signals and Tregs are sensitive to IL-2 stimulation in part due to the high abundance of CD25. As a result, encouraging results have been seen in patients with autoimmune diseases who were treated with low doses of IL-2. Single or repeat low doses of IL-2 led to selective expansion of Tregs over effector cells and provided clinical benefit. Such IL-2 based therapies can be further improved by enhancing the selectivity of IL-2 for Tregs and improving the pharmacokinetics of the drug. Here we have developed an IL-2-Fc fusion protein that selectively acts on Tregs in vitro and in vivo. IL-2 mediated signal transduction occurs through the formation of a high affinity tetrameric complex consisting of IL-2, CD25, CD122(IL-2Rβ) and CD132(IL-2Rγ). IL-2-Fc fusion proteins were designed to be monomeric by fusing variant IL-2 molecules to one side of our heterodimeric Fc-region. To achieve Treg selectivity, we designed variants of IL-2 that have weakened interaction with CD122 and/or enhanced interaction with CD25 such that signaling is only observed in CD25 high cells. These IL-2-Fc variants were produced with good yield and purity. We identified novel variants that selectively led to phosphorylation of STAT5 transcription factor in Tregs from human peripheral blood mononuclear cells (PBMCs). These Treg-selective IL-2-Fc variants stimulated Tregs with varying potencies. Further, they selectively enhanced and sustained the proliferation of Tregs in vivo in non-human primates. These promising preclinical results suggest that clinical development of Treg selective IL-2-Fc fusion proteins for autoimmune diseases is warranted. Disclosures Varma: Xencor: Employment, Equity Ownership. Liu:Xencor: Employment, Equity Ownership. Avery:Xencor: Employment, Equity Ownership. Rashid:Xencor: Employment, Equity Ownership. Schubbert:Xencor: Employment, Equity Ownership. Leung:Xencor: Employment, Equity Ownership. Bonzon:Xencor: Employment, Equity Ownership. Bogaert:Xencor: Employment, Equity Ownership. Desjarlais:Xencor: Employment, Equity Ownership. Bernett:Xencor: Employment, Equity Ownership.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
矮小的猕猴桃完成签到,获得积分10
2秒前
QinMengYao完成签到 ,获得积分10
2秒前
2秒前
mllll发布了新的文献求助50
3秒前
万能图书馆的应助被小芳芳采纳,获得10
3秒前
green完成签到,获得积分10
3秒前
qq完成签到,获得积分10
4秒前
5秒前
5秒前
SciGPT的应助被丹亦采纳,获得10
6秒前
7秒前
yaoyaoy完成签到,获得积分10
8秒前
夕禾完成签到,获得积分10
8秒前
布丁奶绿lv完成签到,获得积分10
8秒前
green发布了新的文献求助10
9秒前
9秒前
和谐秋荷完成签到,获得积分10
9秒前
10秒前
小安发布了新的文献求助10
10秒前
范范范完成签到 ,获得积分10
10秒前
焦哈哈发布了新的文献求助10
10秒前
10秒前
深情安青的应助被乐观冥幽采纳,获得10
10秒前
10秒前
11秒前
11秒前
11秒前
11秒前
11秒前
窦天蓝完成签到,获得积分10
11秒前
11秒前
完美世界的应助被XH采纳,获得10
11秒前
11秒前
11秒前
11秒前
12秒前
12秒前
12秒前
lan2720完成签到 ,获得积分10
12秒前
13秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
Boundaries and Bodhisattvas 500
高分子基功能界面水蒸发材料与应用研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8181892
求助须知:如何正确求助?哪些是违规求助? 9571628
关于积分的说明 21818984
捐赠科研通 7778258
什么是DOI,文献DOI怎么找? 3433556
关于科研通互助平台的介绍 2557720
邀请新用户注册赠送积分活动 2479621